Gene Query: NCEH1

Dataset Description Geneva Score
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 97.94
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 76.59
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 67.94
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 67.94
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 59.2
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 57.85
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 57.75
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 54.97
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 54.86
Silencing SPIB in attached and floating state of H1703 lung cancer cells 52.79
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 50.09
Expression by CD133+ cells isolated from the adult human exocrine pancreas 49.49
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 46.06
The regulartory role of ZCCHC24 in splicing machinery 45.98
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 43.07
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 41.84
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 41.59
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 40.64
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 40.31
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 39.51
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 39.18
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 37.78
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 37.78
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 36.88
STRIPAK directs PP2A activity to promote oncogenic transformation 36.58
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 36.09
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 35.99
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 35.74
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 34.46
Downregulation of LATS kinases alters p53 to promote cell migration 33.68
RNA-seq analyisis of PUM2 knockout cells 32.55
RNA-seq of human aneuploid cell lines with Trisomy 21 32.47
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 32.44
Differential gene expression in Jagged1 treated human dental pulp cells. 32.39
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 32.36
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 32.04
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 31.41
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 30.72
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 30.39
Effect of Influenza virus infection on lncRNA expression in A549 cells 29.56
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 29.53
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 29.1
ARID1A regulates condensin II distribution and chromosomal partition 29.02
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 29.02
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 29.0
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 28.95
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 28.87
SUV420H2 knockdown in PANC-1 28.67
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 28.29
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 28.26
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 28.2
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 28.2
Functional role of CPPED1 in trophoblasts. 28.17
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 28.01
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 27.12
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 26.35
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 26.19
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 26.13
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 26.13
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 25.85
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 25.79
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 25.79
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 25.56
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 25.54
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 25.54
Identification of Sin3B regulated genes during quiescence 25.51
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 25.33
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 25.33
ARS2 is a general suppressor of pervasive transcription [RNAseq] 25.33
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 25.09
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 24.87
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 24.84
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 24.42
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 24.27
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 24.14
Transcriptomic profile of human embryonic renal corpuscles 24.07
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 23.95
Expression level comparison under dividing and quiescent states in human primary fibroblasts 23.92
Generation of trichogenic adipose-derived stem cells by expression of three factors 23.64
Transcriptomic analyssis following EHMT1/2 inhibition 23.49
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 23.43
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 23.38
Differential analysis of gene regulation at transcript resolution by RNA-Seq 23.38
RNA-seq of young and quiescent MRC-5 human fibroblasts 23.36
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 23.22
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 23.19
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 23.17
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 22.85
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 22.85
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 22.54
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 22.54
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 22.47
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 22.08
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 21.84
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 21.63
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 21.56
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 21.24
RNA sequencing of matched nephrectomy samples [RNA-seq] 21.24
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 21.12
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 20.94
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 20.91
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 20.79
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 20.49
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 20.43
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 20.42
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 20.33
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 20.31
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 20.31
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 20.3
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 20.13
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 19.97
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 19.97
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 19.95
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 19.86
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 19.74
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 19.71
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  19.65
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 19.19
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 19.12
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 19.04
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 18.78
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 18.75
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 18.67
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 18.63
Ribosomal footprinting of MDA-Parental and MDA-LM2 18.48
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.14
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 17.98
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 17.94
RNA-Seq analysis of breast cancer cells after shikonin treatment 17.7
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 17.65
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 17.65
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 17.31
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 17.23
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 17.15
Analysis of transcriptional regulation by Myt1 and Myt1l 17.15
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 16.98
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 16.98
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 16.98
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 16.94
Trascriptome of thyroid cancer-induced macrophages 16.71
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 16.66
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 16.63
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 16.36
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 16.36
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 16.31
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 16.31
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 16.23
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 16.13
Fbxo32 mediated gene expression program underlies EMT and metastasis 15.95
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 15.9
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 15.86
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 15.84
Cajal bodies are linked to genome conformation 15.71
Cajal bodies are linked to genome conformation [RNA-Seq] 15.71
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 15.65
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 15.64
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 15.64
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 15.51
IRF2 is a master regulator of human keratinocyte stem cell fate 15.51
A transcriptome dataset revealing the molecular features of breast cancer stem cells 15.5
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 15.41
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 15.17
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 15.13
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 15.13
Oncogenic MYC induces a dependency on the spliceosome in human cancer 15.02
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 14.96
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 14.9
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 14.9
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 14.84
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 14.78
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 14.78
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 14.73
TFAP2C signalling in human fibroblasts 14.68
TCF7L1 knockdown in pancreatic cancer 14.66
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 14.62
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 14.59
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.59
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.59
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 14.58
Transcriptome profiling of 5 human adenocarcinoma cell lines 14.47
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 14.45
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 14.4
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 14.33
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 14.27
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 14.13
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 14.05
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 13.97
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 13.78
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 13.73
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 13.67
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 13.63
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 13.6
AUF-1 affected genes in human skin cells 13.45
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  13.45
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 13.4
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 13.4
NHLRC1 re-expression in cancer cells 13.29
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 13.23
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 13.22
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 13.17
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 13.17
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 13.0
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 13.0
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 12.98
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 12.92
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 12.91
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 12.91
Zika virus infection reprograms global transcription of host cells to allow sustained infection 12.89
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 12.84
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 12.84
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.82
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 12.81
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 12.76
Chromatin landscape of human visceral and subcutaneous adipocytes 12.73
Gene Expression Profiling of SPOP Knocked Down Cell 12.71
Molecular Mechanisms of Endothelial Hyperpermeability 12.65
Identification of the role of polydom in neurofibromas 12.63
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 12.5
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.43
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 12.33
RNA-seq analysis of breast cancer 12.32
RNA-seq analysis and shRNA screen of breast cancer 12.32
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 12.27
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 12.26
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 12.21
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 12.13
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 12.13
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 12.12
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 12.09
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 11.96
hnRNP C is a key regulator of protein synthesis in mitosis 11.95
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 11.93
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.89
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 11.8
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 11.8
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 11.75
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 11.75
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 11.71
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 11.71
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 11.68
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 11.66
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 11.66
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 11.64
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 11.47
Developmental stage specific chromosome architecture in human erythroid cells 11.42
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 11.42
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 11.38
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 11.38
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 11.26
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 11.24
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 11.2
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.18
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.15
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 11.1
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 11.1
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.08
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 11.07
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 11.03
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 10.96
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 10.96
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 10.94
ARID1A and ARID1B loss in HCT116 and TOV21G cells 10.87
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 10.83
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 10.83
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 10.77
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 10.77
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 10.75
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.74
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.74
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 10.68
Inhibition of TNBC metastasis by Gpx1 10.61
ZIKV infection of monocytes activates inflammasome pathways 10.58
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 10.56
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 10.56
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 10.55
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 10.51
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 10.51
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 10.44
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.43
TGF-β promotes genomic instability after loss of RUNX3 10.39
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 10.3
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 10.26
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 10.26
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 10.24
Copper Regulation of HIF-1 Transcription Activity 10.22
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 10.22
Enhancer activation during EGF response 10.19
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 10.15
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 10.14
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 10.11
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 10.07
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 10.06
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 10.06
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 9.99
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 9.89
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 9.77
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 9.77
Characterization of parental and rociletinib-resistant derived H1975 cell lines 9.75
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 9.65
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 9.64
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 9.62
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 9.6
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 9.55
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 9.55
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 9.53
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 9.49
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 9.45
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 9.35
U1 snRNP telescripting regulates size-function stratified human genome 9.27
High-Throughput Kinetic Analysis of Fractional Killing 9.25
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 9.22
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 9.21
Efficient derivation of microglia-like cells from human pluripotent stem cells 9.16
Transcriptome of U251 cells overexpression complement component 7 9.14
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 9.01
AMPK signaling for naïve pluripotency [Hs] 8.91
AMPK signaling for naïve pluripotency 8.91
TOP2B disturbed the quality of human oocytes with advanced maternal age 8.9
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.77
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 8.69
Gene expression profiling of human and murine in vitro muscle differentiation 8.48
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 8.43
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.41
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.41
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 8.37
RNA-seq analysis upon ARID1B overexpression 8.14
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 8.1
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 8.07
Gene expression analysis of human liver progenitor-like cells in culture 8.05
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 8.04
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 8.03
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 7.95
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 7.79
The effect of PPARG inhibition on human angiomyolipoma cells 7.77
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 7.76
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 7.72
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 7.67
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.54
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 7.51
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.39
The effect of Abl kinases on non-small cell carcinoma global transcriptome 7.38
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 7.36
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 7.36
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 7.34
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 7.28
RNA seq_PDX2_SHP099 7.2
Transcriptomes of oxLDL exposed trained monocytes 7.2
oxLDL exposed trained monocytes 7.2
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 7.18
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 7.18
Transcriptional responses of melanoma cells to BRAF inhibition 7.18
mRNA sequencing of oropharyngeal cancer cell lines 7.16
MRTF activates TEAD-YAP target gene expression 7.07
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 7.0
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 6.91
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 6.84
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 6.79
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 6.78
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 6.71
EGR1-controlled transcriptome of T HESCs 6.71
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.53
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 6.47
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.43
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 6.39
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 6.34
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.14
Transcriptomes of human monocytes after ex vivo exposure to uric acid 6.0
Identification of differentially expressed genes between senescence and senescence bypass cells 5.94
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 5.86
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.8
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 5.68
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 5.53
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 5.53
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 5.45
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.41
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.35
RNAseq in Alzheimer's Disease patients 5.29
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 5.25
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.22
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 5.18
Nucleoporin-mediated regulation of cell identity genes 5.18
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 5.17
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 5.12
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 5.12
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 5.1
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.09
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 5.03
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 4.97
nELAVL HITS-CLIP in Alzheimer's Disease patients 4.93
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 4.93
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.79
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.74
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 4.7
Regulation of poly(A) tail and translation during the somatic cell cycle 4.69
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 4.6
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 4.58
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 4.49
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.4
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.4
RNA-seq of cancer cell lines treated with T-025 4.4
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 4.37
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 4.37
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.32
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.31
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 4.29
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 4.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 4.17
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.1
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 4.0
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 4.0
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.97
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.89
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 3.87
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 3.86
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 3.81
Specific molecular signatures underlie response to decitabine in CMML 3.81
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.79
Positively selected enhancer elements endow tumor cells with metastatic competence 3.75
6mer seed toxicity in viral microRNAs 3.73
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.68
Generation and functional characterization of MDSC-like cells 3.64
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 3.59
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.58
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.52
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.49
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 3.34
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.91
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.82
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.82
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.77
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.75
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 2.74
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 2.71
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 2.68
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 2.68
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.65
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.58
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 2.55
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 2.33
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.33
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.33
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.31
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.3
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.29
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.29
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.29
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.29
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 2.26
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 2.12
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 2.12
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 2.03
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.0
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.92
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.92
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.85
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.85
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.83
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.53
The cytokine environment influence on human skin-derived T cells 1.4
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.37
Random mono-allelic expression in MECP2-mutated cells 1.37
Gene expression profile of CRC-derived HILEC 1.33
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.31
Human islets of varying quality: the good, the (not so) bad and the ugly 1.31
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.3
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.3
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.29
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.12
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.06
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.03
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.03
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.03
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.98
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.76
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.74
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.74
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.64
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.64
Transcriptome analyses of human pancreatic islets and pseudoislets 0.64
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 0.6
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.59
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.58
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.57
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.51
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.47
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.46
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.45
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.43
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 0.34
Effects of transcription on genome - nuclear lamina interactions 0.31
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.31
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.31
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.26
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.25
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.24
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.15
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.12
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.12
BMS-470539 on human synovial fibroblasts 0.11
Finding missing proteins from epigenetically manipulated human cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation